Cargando…
Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report()
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA is detectable in nasopharyngeal specimens for up to 12–20 days regardless of the presence of chronic diseases in patients. We report a case of prolonged SARS-CoV-2 infection that lasted for more than eight weeks. The patient had persis...
Autores principales: | Arai, Tatsuya, Mukai, Satoru, Kazama, Ryo, Ogawa, Yoshihiko, Nishida, Koji, Hatanaka, Kazuo, Gohma, Iwao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801906/ https://www.ncbi.nlm.nih.gov/pubmed/35115239 http://dx.doi.org/10.1016/j.jiac.2022.01.014 |
Ejemplares similares
-
Clinical characteristics of patients with coronavirus disease 2019–associated pulmonary aspergillosis on mechanical ventilation: A single-center retrospective study in Japan
por: Ogawa, Yoshihiko, et al.
Publicado: (2023) -
Bendamustine/rituximab: Prolonged SARS-CoV-2 viral shedding : case report
Publicado: (2022) -
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
por: Ogawa, Yoshihiko, et al.
Publicado: (2020) -
Assessing the effects of exposure to a SARS-CoV-2 re-positive patient in healthcare personnel
por: Ogawa, Yoshihiko, et al.
Publicado: (2020) -
Bendamustine/remdesivir/rituximab: Lymphocytopenia, hypogammaglobulinaemia and rebound viral shedding following drug resistance: case report
Publicado: (2022)